Stocks
Sarepta Therapeutics, Inc.SRPT
NASDAQHealthcareBiotechnology$16.40-3.76%
Focused on genetic medicine, the company develops therapies for rare neuromuscular diseases, with a primary emphasis on treatments for Duchenne muscular dystrophy. Its portfolio includes approved exon-skipping therapies and a developing pipeline of gene therapies targeting underlying genetic mutatio...
Market Cap: $1.7B52W Range: $10.42 – $103.32
This page tracks all publicly disclosed congressional trades in Sarepta Therapeutics, Inc. (SRPT), a company in the Healthcare sector. 5 members of Congress have disclosed trades in this stock, including 13 purchases and 6 sales. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
Total Disclosures
19
Unique Politicians
5
Buys
13
Sells
6
Congressional Trading History
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-04-14 | Gilbert Cisneros | sell | $1K – $15K |
| 2024-11-26 | Rohit Khanna | buy | $1K – $15K |